Top

Clinical and Translational Oncology

Published in:

01-12-2006 | Educational Series

New potential therapeutic targets to combat epithelial tumor invasion

Authors: Héctor Peinado, Amparo Cano

Published in: Clinical and Translational Oncology | Issue 12/2006

Title: New potential therapeutic targets to combat epithelial tumor invasion
Authors: Héctor Peinado
Amparo Cano
Publication date: 01-12-2006
Publisher: Springer-Verlag
Published in: Clinical and Translational Oncology / Issue 12/2006
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-006-0148-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 12/2006

Are the olive oil and other dietary lipids related to cancer? Experimental evidence

Tumour banks in pediatric oncology

Randomized Study of Cefepime versus Ceftazidime plus Amikacin in Patients with Solid Tumors Treated with High Dose Chemotherapy (HDC) and Peripheral Blood Stem Cell Support (PBSCS) with Febrile Neutropenia

It is about time that spain launches a National Cancer Act?

Viral gene therapy

Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer